RESEARCH FRONTIERS INC — Investor Relations & Filings
Filings indexed
900
across all filing types
Latest filing
2026-05-08
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
REFR
Research Frontiers Inc. is a technology company that develops and licenses its patented Suspended Particle Device (SPD) light-control technology. Marketed as SPD-SmartGlass, this technology enables glass and plastic surfaces to instantly and precisely switch from clear to a user-controlled level of tint. The system operates via a film containing microscopic particles that align when an electrical voltage is applied, regulating the passage of light. Key features include rapid transition speed, variable tint control, and the ability to block over 99% of UV radiation and significant heat, enhancing energy efficiency. The company licenses its technology to a global network of partners for use in products across the automotive, aviation, marine, rail, and architectural industries.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-08 | English | |
| DEF 14A | 2026-04-30 | English | |
| 10-K/A - RESEARCH FRONTIERS INC (0000793524) (Filer) | 2026-03-19 | English | |
| 10-K | 2026-03-05 | English | |
| 8-K - RESEARCH FRONTIERS INC (0000793524) (Filer) | 2026-02-18 | English | |
| 4 Filing | 2026-01-05 | English |
Browse filings by year
32 years- 2026 8 filings
- 2025 14 filings
- 2024 15 filings
- 2023 20 filings
- 2022 14 filings
- 2021 17 filings
- 2020 37 filings
- 2019 27 filings
- 2018 53 filings
- 2017 31 filings
- 2016 25 filings
- 2015 44 filings
- 2014 59 filings
- 2013 64 filings
- 2012 54 filings
- 2011 32 filings
- 2010 34 filings
- 2009 41 filings
- 2008 27 filings
- 2007 51 filings
- 2006 24 filings
- 2005 55 filings
- 2004 51 filings
- 2003 45 filings
- 2002 5 filings
- 2001 11 filings
- 2000 6 filings
- 1999 9 filings
- 1998 8 filings
- 1997 9 filings
- 1996 8 filings
- 1995 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46101131 | 10-Q | 2026-05-08 | English | ||
| 46101110 | DEF 14A | 2026-04-30 | English | ||
| 32989157 | 10-K/A - RESEARCH FRONTIERS INC (0000793524) (Filer) | 2026-03-19 | English | ||
| 46101193 | 10-K | 2026-03-05 | English | ||
| 32881385 | 8-K - RESEARCH FRONTIERS INC (0000793524) (Filer) | 2026-02-18 | English | ||
| 18681422 | 4 Filing | 2026-01-05 | English | ||
| 18681406 | 4 Filing | 2026-01-05 | English | ||
| 18681397 | 4 Filing | 2026-01-05 | English | ||
|
2025
7 filings
| |||||
| 9588051 | 10-Q | 2025-11-06 | English | ||
| 9588052 | Major Shareholding Notification 2025 | 2025-10-17 | English | ||
| 9588054 | 8-K | 2025-09-15 | English | ||
| 9588056 | 10-Q | 2025-08-07 | English | ||
| 9588057 | 8-K | 2025-06-13 | English | ||
| 9588058 | 10-Q | 2025-05-08 | English | ||
| 9588059 | Proxy Solicitation & Information Statement 2025 | 2025-04-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
RenovoRx, Inc.
A clinical-stage company developing targeted oncology thera…
|
RNXT | US | Professional, scientific and te… |
|
Repare Therapeutics Inc.
A clinical-stage oncology company developing targeted cance…
|
RPTX | US | Professional, scientific and te… |
|
Replimune Group, Inc.
A clinical-stage biotech developing oncolytic immunotherapi…
|
REPL | US | Professional, scientific and te… |
|
ReproCELL Incorporated
Provider of stem cell technology and services for research …
|
4978 | JP | Professional, scientific and te… |
|
RESONANCE HEALTH LIMITED
Develops non-invasive MRI software for quantitative analysi…
|
RHT | AU | Professional, scientific and te… |
|
Respiratorius AB
A research company developing innovative drug candidates, p…
|
RESP | SE | Professional, scientific and te… |
|
REVELATION BIOSCIENCES, INC.
Clinical-stage biopharma developing immunologic therapies t…
|
REVB | US | Professional, scientific and te… |
|
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Clinical-stage biopharma developing therapeutics for CNS, r…
|
RVPH | US | Professional, scientific and te… |
|
Revolution Medicines, Inc.
Clinical-stage precision oncology company developing therap…
|
RVMD | US | Professional, scientific and te… |
|
R&G PharmaStudies Co., Ltd.
Full-service CRO providing clinical research solutions for …
|
301333 | CN | Professional, scientific and te… |
RESEARCH FRONTIERS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34569/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34569 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34569 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34569 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34569}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RESEARCH FRONTIERS INC (id: 34569)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.